Faculty

Research

Systems

Infrastructure

Patient & Public Awareness

Working with Industry

Research Databases

About Us

News: Circulating tumour cells a promising prognostic in neuroendocrine cancer

Title

Circulating tumour cells a promising prognostic in neuroendocrine cancer 

News Title

Circulating tumour cells a promising prognostic in neuroendocrine cancer 

News Content

A study has found that the presence of cancer cells circulating in the blood could predict the outcome or prognosis of neuroendocrine cancer. The research, published in the Journal of Clinical Oncology, and supported by the NIHR University College London Hospitals Biomedical Research Centre, found that 49% of patients had at least one CTC (cells that have shed into the blood vessels from a primary tumour and circulate in the bloodstream), 42% had two or more CTCs, and 30% had five or more CTCs in 7.5 mL blood. CTC measurements are now being incorporated into trials of new therapies for neuroendocrine cancer. Additional studies are under way to characterise CTCs in terms of their mutational and gene expression profile and this may help to select the best treatment for individual patients in the future.

News Link

Read more 

News Date

15/05/2013 

Expires

14/06/2013 

Date Created

 

Date Modified

 
Attachments
Created at 15/05/2013 17:29  by Leonilde Yahyaoui 
Last modified at 15/05/2013 17:29  by Leonilde Yahyaoui